Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.

被引：0
作者：
Hompland, Ivar
Boye, Kjetil
Papakonstantinou, Andri
Rosok, Bard
Joensuu, Heikki
Bruland, Oyvind
机构：
[1] Oslo Univ Hosp, Oslo, Norway
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Oncoinvent AS, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11535
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
    Joensuu, H.
    De Braud, F.
    Grignagni, G.
    De Pas, T.
    Spitalieri, G.
    Coco, P.
    Spreafico, C.
    Boselli, S.
    Toffalorio, F.
    Bono, P.
    Jalava, T.
    Kappeler, C.
    Aglietta, M.
    Laurent, D.
    Casali, P. G.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1686 - 1690
  • [12] Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
    H Joensuu
    F De Braud
    G Grignagni
    T De Pas
    G Spitalieri
    P Coco
    C Spreafico
    S Boselli
    F Toffalorio
    P Bono
    T Jalava
    C Kappeler
    M Aglietta
    D Laurent
    P G Casali
    British Journal of Cancer, 2011, 104 : 1686 - 1690
  • [13] Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial
    George, Suzanne
    Wang, Qian
    Heinrich, Michael C.
    Corless, Christopher L.
    Zhu, Meijun
    Butrynski, James E.
    Morgan, Jeffrey A.
    Wagner, Andrew J.
    Choy, Edwin
    Tap, William D.
    Yap, Jeffrey T.
    Van den Abbeele, Annick D.
    Manola, Judith B.
    Solomon, Sarah M.
    Fletcher, Jonathan A.
    von Mehren, Margaret
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (19) : 2401 - 2407
  • [14] A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors ( GIST) following failure of at least imatinib and sunitinib
    Ganjoo, K. N.
    Villalobos, V. M.
    Kamaya, A.
    Fisher, G. A.
    Butrynski, J. E.
    Morgan, J. A.
    Wagner, A. J.
    D'Adamo, D.
    McMillan, A.
    Demetri, G. D.
    George, S.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 236 - 240
  • [15] Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    Bauer, S.
    Hilger, R. A.
    Muehlenberg, T.
    Grabellus, F.
    Nagarajah, J.
    Hoiczyk, M.
    Reichardt, A.
    Ahrens, M.
    Reichardt, P.
    Grunewald, S.
    Scheulen, M. E.
    Pustowka, A.
    Bock, E.
    Schuler, M.
    Pink, D.
    BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1155 - 1162
  • [16] Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
    Cho, H.
    Ryu, M-H.
    Kim, B. J.
    Park, Y.
    Na, Y-S.
    Ma, J.
    Beck, M. Y.
    Kang, Y-K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [17] Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study
    Kim, E.
    Ryu, M-H.
    Park, S. R.
    Beck, M. Y.
    Lee, W. J.
    Lee, M. W.
    Kang, Y-K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [18] Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study
    Kim, Eo Jin
    Ryu, Min-Hee
    Park, Sook Ryun
    Beck, Mo Youl
    Lee, Woo Jin
    Lee, Mi Woo
    Kang, Yoon-Koo
    ONCOLOGIST, 2020, 25 (11) : E1785 - E1793
  • [19] Outcome of adjuvant imatinib in patients with gastrointestinal stromal tumor: Results of a population-based, matched cohort study.
    Hatoum, H. T.
    Trent, J. C.
    Guo, A.
    Lin, S.
    Sirulnik, L. A.
    Sasane, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [20] Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    S Bauer
    R A Hilger
    T Mühlenberg
    F Grabellus
    J Nagarajah
    M Hoiczyk
    A Reichardt
    M Ahrens
    P Reichardt
    S Grunewald
    M E Scheulen
    A Pustowka
    E Bock
    M Schuler
    D Pink
    British Journal of Cancer, 2014, 110 : 1155 - 1162
12345